Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2016 - 2020
Revenue	829.45	3.55	240.74	243.23	138.29	Upgrade
Revenue Growth (YoY)	23258.15%	-98.52%	-1.03%	75.89%	57.16%	Upgrade
Gross Profit	829.45	3.55	240.74	243.23	138.29	Upgrade
Selling, General & Admin	138.5	113.44	104.08	132.44	85.44	Upgrade
Research & Development	592.6	491.19	341.66	289.3	201.88	Upgrade
Operating Expenses	731.1	604.63	445.74	421.74	287.32	Upgrade
Operating Income	98.35	-601.08	-205	-178.51	-149.04	Upgrade
Interest Expense	-89.36	-32.35	-18.33	-	-	Upgrade
Interest & Investment Income	37.29	22.72	15.3	5.03	6.12	Upgrade
Other Non Operating Income (Expenses)	5.26	-1.75	1.54	0.77	2.07	Upgrade
EBT Excluding Unusual Items	51.53	-612.46	-206.49	-172.71	-140.85	Upgrade
Pretax Income	51.53	-612.46	-206.49	-172.71	-140.85	Upgrade
Income Tax Expense	21.42	-2.77	2.78	3.79	0	Upgrade
Earnings From Continuing Operations	30.11	-609.69	-209.28	-176.49	-140.85	Upgrade
Minority Interest in Earnings	-31.75	10.2	4	0.43	-	Upgrade
Net Income	-1.63	-599.49	-205.28	-176.06	-140.85	Upgrade
Net Income to Common	-1.63	-599.49	-205.28	-176.06	-140.85	Upgrade
Shares Outstanding (Basic)	134	120	107	105	104	Upgrade
Shares Outstanding (Diluted)	134	120	107	105	104	Upgrade
Shares Change (YoY)	11.67%	12.21%	1.26%	1.62%	3.00%	Upgrade
EPS (Basic)	-0.01	-5.00	-1.92	-1.67	-1.36	Upgrade
EPS (Diluted)	-0.01	-5.00	-1.92	-1.67	-1.36	Upgrade
Free Cash Flow	156.89	-604.32	-330.63	-188.91	147.75	Upgrade
Free Cash Flow Per Share	1.17	-5.04	-3.10	-1.79	1.42	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	11.86%	-16927.06%	-85.16%	-73.39%	-107.77%	Upgrade
Profit Margin	-0.20%	-16882.37%	-85.27%	-72.39%	-101.85%	Upgrade
Free Cash Flow Margin	18.92%	-17018.31%	-137.34%	-77.67%	106.84%	Upgrade
EBITDA	122.27	-582.49	-192.51	-168.09	-140.77	Upgrade
EBITDA Margin	14.74%	-	-79.97%	-69.11%	-101.79%	Upgrade
D&A For EBITDA	23.93	18.6	12.49	10.42	8.27	Upgrade
EBIT	98.35	-601.08	-205	-178.51	-149.04	Upgrade
EBIT Margin	11.86%	-	-85.16%	-73.39%	-107.77%	Upgrade
Effective Tax Rate	41.56%	-	-	-	-	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.